A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.
暂无分享,去创建一个
[1] K. Bruxvoort,et al. Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018. , 2019, Vaccine.
[2] R. Forshee,et al. Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18. , 2019, The Journal of infectious diseases.
[3] L. Demarcus,et al. Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season. , 2019, Vaccine.
[4] Pirada Suphaphiphat,et al. 2556. Retrospective Evaluation of Mismatch From Egg-Based Isolation of Influenza Strains Compared With Cell-Based Isolation and the Possible Implications for Vaccine Effectiveness , 2018, Open Forum Infectious Diseases.
[5] I. Barr,et al. Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness , 2018, npj Vaccines.
[6] N. Heaton,et al. Efforts to Improve the Seasonal Influenza Vaccine , 2018, Vaccines.
[7] I. Wilson,et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine , 2017, PLoS pathogens.
[8] L. Grohskopf,et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season , 2017, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[9] Colin Simpson,et al. Effectiveness of Influenza Vaccines in Asthma: A Systematic Review and Meta-Analysis , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] R. Stirling,et al. Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018. , 2017, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[11] Anthony D. Ong,et al. A Primer on Inverse Probability of Treatment Weighting and Marginal Structural Models , 2016 .
[12] C. Robertson,et al. Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines. , 2015, Vaccine.
[13] L. Grohskopf,et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[14] E. Stuart,et al. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies , 2015, Statistics in medicine.
[15] D. Skowronski,et al. Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.
[16] William H Crown,et al. Propensity-Score Matching in Economic Analyses: Comparison with Regression Models, Instrumental Variables, Residual Inclusion, Differences-in-Differences, and Decomposition Methods , 2014, Applied Health Economics and Health Policy.
[17] T. Welte,et al. Influenza vaccination is associated with reduced severity of community-acquired pneumonia , 2010, European Respiratory Journal.
[18] P. Austin. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.
[19] Manon M J Cox,et al. FluBlok, a next generation influenza vaccine manufactured in insect cells. , 2009, Biologicals : journal of the International Association of Biological Standardization.
[20] A. Basu,et al. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. , 2005, Biostatistics.